$254 Million is the total value of Tri Locum Partners LP's 41 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 175.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | New | ABBVIE INC | $24,365,000 | – | 179,950 | +100.0% | 9.59% | – |
| LLY | New | LILLY ELI & CO | $21,691,000 | – | 78,528 | +100.0% | 8.54% | – |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $19,095,000 | +37.3% | 147,396 | +20.0% | 7.52% | +36.0% |
| ARGX | New | ARGENX SEsponsored adr | $16,931,000 | – | 48,347 | +100.0% | 6.67% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $15,886,000 | +5697.8% | 436,300 | +2619.2% | 6.25% | +5637.6% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $15,048,000 | – | 318,269 | +100.0% | 5.92% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $12,248,000 | – | 732,515 | +100.0% | 4.82% | – |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $12,232,000 | -6.7% | 506,280 | +0.3% | 4.82% | -7.5% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $10,736,000 | – | 313,929 | +100.0% | 4.23% | – |
| ACET | New | ADICET BIO INC | $10,204,000 | – | 583,402 | +100.0% | 4.02% | – |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $9,919,000 | +63.6% | 45,904 | +39.7% | 3.90% | +62.0% |
| INBX | New | INHIBRX INC | $9,309,000 | – | 213,174 | +100.0% | 3.66% | – |
| SGEN | Sell | SEAGEN INC | $9,267,000 | -43.3% | 59,940 | -37.8% | 3.65% | -43.9% |
| FATE | New | FATE THERAPEUTICS INC | $8,310,000 | – | 142,032 | +100.0% | 3.27% | – |
| BLU | Buy | BELLUS HEALTH INC NEW | $7,856,000 | +31.5% | 975,933 | +0.3% | 3.09% | +30.3% |
| EVH | New | EVOLENT HEALTH INCcl a | $6,228,000 | – | 225,097 | +100.0% | 2.45% | – |
| New | STEVANATO GROUP S P A | $5,089,000 | – | 226,700 | +100.0% | 2.00% | – | |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $4,187,000 | -50.8% | 89,840 | -46.7% | 1.65% | -51.3% |
| XFOR | New | X4 PHARMACEUTICALS INC | $3,616,000 | – | 1,578,947 | +100.0% | 1.42% | – |
| New | SCIENCE 37 HOLDINGS INC | $3,381,000 | – | 271,159 | +100.0% | 1.33% | – | |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $3,355,000 | – | 24,346 | +100.0% | 1.32% | – |
| CTLT | New | CATALENT INC | $3,034,000 | – | 23,700 | +100.0% | 1.19% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $1,987,000 | – | 23,632 | +100.0% | 0.78% | – |
| ABMD | New | ABIOMED INC | $1,857,000 | – | 5,169 | +100.0% | 0.73% | – |
| SKIN | New | THE BEAUTY HEALTH COMPANYcall | $1,788,000 | – | 74,000 | +100.0% | 0.70% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $1,768,000 | – | 48,141 | +100.0% | 0.70% | – |
| TCDA | New | TRICIDA INC | $1,623,000 | – | 169,786 | +100.0% | 0.64% | – |
| CYTK | New | CYTOKINETICS INC | $1,521,000 | – | 33,379 | +100.0% | 0.60% | – |
| NVAX | Sell | NOVAVAX INCcall | $1,517,000 | -62.1% | 10,600 | -45.1% | 0.60% | -62.5% |
| ONEM | New | 1LIFE HEALTHCARE INC | $1,489,000 | – | 84,748 | +100.0% | 0.59% | – |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $1,370,000 | – | 26,177 | +100.0% | 0.54% | – |
| AMWL | New | AMERICAN WELL CORPcl a | $1,358,000 | – | 224,876 | +100.0% | 0.54% | – |
| CANO | New | CANO HEALTH INC | $1,261,000 | – | 141,508 | +100.0% | 0.50% | – |
| VIR | New | VIR BIOTECHNOLOGY INCput | $1,256,000 | – | 30,000 | +100.0% | 0.49% | – |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $1,008,000 | – | 40,571 | +100.0% | 0.40% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $806,000 | – | 55,433 | +100.0% | 0.32% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $782,000 | -80.6% | 25,043 | -90.5% | 0.31% | -80.8% |
| FEMY | Sell | FEMASYS INC | $568,000 | -56.7% | 145,631 | -23.6% | 0.22% | -57.1% |
| DRRX | New | DURECT CORP | $26,000 | – | 26,387 | +100.0% | 0.01% | – |
| AWH | New | ASPIRA WOMENS HEALTH INC | $19,000 | – | 10,876 | +100.0% | 0.01% | – |
| ATHX | New | ATHERSYS INC NEW | $18,000 | – | 19,449 | +100.0% | 0.01% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -129,192 | -100.0% | -0.38% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -148,355 | -100.0% | -0.58% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -5,506 | -100.0% | -0.60% | – |
| LSAQ | Exit | LIFESCI ACQUISITION II CORP | $0 | – | -263,289 | -100.0% | -1.02% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -522,943 | -100.0% | -1.10% | – |
| CCXI | Exit | CHEMOCENTRYX INCcall | $0 | – | -276,400 | -100.0% | -1.88% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -377,708 | -100.0% | -2.44% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -122,503 | -100.0% | -2.72% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -1,810,672 | -100.0% | -2.88% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -13,950 | -100.0% | -3.36% | – |
| MRK | Exit | MERCK & CO INCcall | $0 | – | -150,500 | -100.0% | -4.49% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -135,055 | -100.0% | -4.96% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -104,070 | -100.0% | -5.18% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -181,765 | -100.0% | -5.42% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -312,847 | -100.0% | -5.85% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INCcall | $0 | – | -350,000 | -100.0% | -6.54% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -312,400 | -100.0% | -9.98% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -261,500 | -100.0% | -11.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.